Cartesian Therapeutics
Price & Volume
Stats
See more52W Range | $8.46-$26.50 |
Market Cap | $351.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $34.1M |
Revenue Growth (YoY) | -81.2% |
Gross Profit (12 Mos) | -$15.8M |
Diluted EPS | $5.33 |
News
See moreYahoo Finance • 3 days ago
Wedbush initiates coverage on Cartesian Therapeutics stock with Outperform rating
Yahoo Finance • last month
Cartesian Therapeutics Announces New Employment Inducement Grants
Yahoo Finance • last month
Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
Yahoo Finance • 3 months ago
Cartesian Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
About
CEO | Dr. Carsten Brunn Ph.D. |
Address | 7495 New Horizon Way, Frederick, MD, United States, 21703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 66 |
